跳至主要内容
临床试验/NCT06455371
NCT06455371招募中不适用

Patient-centered Decision Support Tool for Levothyroxine Dosage

University Hospital of North Norway4 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2024年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
240
试验地点
4
主要终点
Number of patients at biochemical target

研究概览

简要总结

Levothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have developed a decision support tool (DST) that predicts optimal dosage based on repeated blood samples the first 2 weeks after initiation of therapy. In this randomized study the investigators will include patients that start levothyroxine therapy after total thyroidectomy. The use of DST to advice the physician about an early dosage adjustment will be compared with common clinical practice, that is dosage adjustment every 2 months. The effect of DST use will be assessed by studying the possible relationship between fast optimal dose adjustment, patient reported outcome measures, and ability to work.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Total or completion thyroidectomy for differentiated thyroid cancer og benign thyroid nodules at Norwegian hospitals

排除标准

  • Anaplastic thyroid cancer, thyroid cancer with distant metastasis, graves disease, toxic nodules, pregnancy

结局指标

主要结局

Number of patients at biochemical target

时间窗: Outcome is measured at 8 weeks, 6 months and 12 months post surgery

Number of patients at biochemical target. Biochemical target is TSH (thyroid stimulating hormone) 0,5-2,0 mIE/L for patients on substitution therapy and 0,1-0,5 mIE/L for patients on suppression therapy

次要结局

  • Time to biochemical target(Measured at 18 months after surgery)
  • Distance from biochemical target(Measured at 8 weeks post surgery)
  • Patient reported outcome - ThyPRO39 questionnaire(Measured at 2 weeks before surgery, 2 months after surgery and 6 months after surgery surgery)
  • Patient reported outcome - RAND-36 questionnaire(Measured at 2 weeks before surgery, 2 months after surgery and 6 months after surgery surgery)
  • Abscence from work(Measured at18 months after surgery)

研究者

发起方
University Hospital of North Norway
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vegard Brun

Consultant physician and associate professor

University Hospital of North Norway

研究点 (4)

Loading locations...

相似试验